Cure for male pattern baldness given boost by sugar discovery
Researchers have identified a DNA-related sugar, 2-deoxy-D-ribose, that promotes blood vessel growth and may regrow hair as effectively as Minoxidil, reigniting hopes for a treatment for male pattern baldness. Commenters weigh this against existing options like Minoxidil, finasteride, dutasteride, PRP, and hair transplants, debating their efficacy, long‑term side effects, and the tradeoff of taking systemic drugs for a largely cosmetic issue. Many also reflect on how deeply hair loss affects self-image, attraction, and social treatment, with some arguing for better medical solutions and others urging cultural acceptance of baldness instead of framing it as a disease needing a “cure.”
Promise and Mechanism of the New Sugar (2-deoxy-D-ribose)
- Commenters note existing literature that 2dDR promotes angiogenesis via VEGF and aids wound healing; the observed faster hair growth around treated wounds seems plausible.
- Some argue better scalp vascularization is likely beneficial for hair and possibly skin, but this is speculative.
- Others warn angiogenesis can also support tumor growth, and the scalp is already a common skin‑cancer site, so safety must be studied carefully.
- The article’s claim that it’s “as effective as Minoxidil” dampens enthusiasm for some, since Minoxidil is seen by several as modest at best.
Comparisons to Existing Hair-Loss Treatments
- Minoxidil:
- Experiences range from “barely effective” to “extremely effective,” especially orally or when started early; can regrow some hair but requires lifelong use.
- Some report severe cardiovascular side effects (chest pain, “heart attack” feeling).
- Finasteride/Dutasteride:
- Widely acknowledged to significantly slow or partially reverse androgenic hair loss by suppressing DHT.
- Some see dutasteride as “almost a cure” if started early; others stress increased systemic impact vs finasteride.
- Reported side effects: reduced libido, ED, mood changes, depression, suicidal thoughts, fertility concerns, gynecomastia; others insist these are rare, overblown, or largely nocebo.
- Alternative/adjunct options:
- PRP injections, hair transplants (FUE) reported as effective but costly, with varying durability and need for ongoing maintenance (PRP, meds).
- A cited rosemary oil study claims Minoxidil‑like efficacy with fewer side effects.
- Cyclosporin and keto/“nutrient” angles are mentioned but not developed into clear, safe protocols.
Safety, Hormones, and Systemic Effects
- Extended debate on how finasteride affects testosterone, DHT, and endocrine feedback loops; outcomes and reversibility seen as uncertain.
- Some emphasize DHT may have neuroprotective roles; others dismiss adult DHT as mostly harmful.
- A trans poster describes complex tradeoffs between estrogen therapy, finasteride, sexual function, and hair preservation.
Psychological, Social, and Evolutionary Aspects
- Strong divide between “accept it, shave it” advocates and those who see that as dismissive of real distress.
- Many say baldness significantly harms self‑image, dating prospects, and social treatment, especially with early onset; others argue confidence, fitness, grooming, and personality can fully compensate.
- Multiple comments stress that balding (in‑between stage) looks much worse than fully shaved.
- Some argue calling it a “cure” pathologizes natural aging; others counter that people routinely “cure” unwanted but natural traits (nose shape, wrinkles, obesity).
- Evolutionary arguments appear on both sides: hair as a sign of youth/health vs claims that baldness itself may not be strongly selected against.
Access, Cost, and Medical Gatekeeping
- One poster describes a doctor refusing finasteride due to side‑effect concerns, leaving them feeling abandoned; others recommend seeking another doctor or sourcing meds independently, raising issues of cost and safety.
- Someone notes 2dDR is already sold as a supplement, but no one in the thread reports trying it for hair.
Meta: Skepticism About the Hype
- Several commenters are wary of PR fluff and note the university press release didn’t even link the underlying paper (later shared by another poster).
- The Minoxidil analogy (hypertension drug → hair drug) makes some suspect this may end up similarly modest, not a true “cure.”